In July 2015, a 32-year-old bright and budding L.A.-based comedian was told he had one year left to live. Diagnosed with stage 4 peritoneal mesothelioma, Quincy Jones, a name the comedian shares with the famous music producer, realized he couldn’t wait any longer to leave a legacy.
For more than three decades, Gayla Benefield has been at the center of tragic events unfolding in Libby, Montana. Three generations of her family have died or become sick from asbestos-related diseases traced to a mine operated by W. R. Grace.
A recent cancer diagnosis can result in feelings of fear and confusion. Often, patients and families feel a sense of information overload when they are first diagnosed. It’s difficult to know how to begin the most effective treatment and who to rely on for cancer care. An important place to start is by choosing a trusted physician who is an expert not just in cancer, but in the particular cancer with which you have been diagnosed. In addition, the doctor should have a reputation for taking time with patients and a quality bedside manner. Your doctor should be able to balance the latest scientific expertise, communication skills, and the ability to make you feel as comfortable as possible.
The advocacy efforts of Asbestos Awareness Week, starting April 1st, shouldn’t come to an end on the 7th. On April 9th through the 10th, the Asbestos Disease Awareness Organization (ADAO) invites mesothelioma victims, loved ones, and community members to our 12th Annual International Asbestos Awareness and Prevention Conference, “Where Knowledge and Action Unite,” in Washington, D.C.
On February 29th, Nature Genetics published the results of a comprehensive mesothelioma gene-sequencing study conducted by our team of researchers at the International Mesothelioma Program (IMP) at Brigham and Women’s Hospital and scientists from Genentech. This seminal study provides new genetic insight into mesothelioma and offers a broader understanding of the disease’s mutation patterns. Through a comprehensive genomic analysis of over 200 mesothelioma tumors, our team of researchers identified several previously unknown genetic mutations and recurrent mutations within mesothelioma. The results prove the validity of sequencing mesothelioma tumors in the same way other forms of cancer are sequenced to determine targeted therapies. This study is the largest genetic analysis of mesothelioma thus far and could be a game-changer for identifying better targeted treatments.
The Mesothelioma Cancer Alliance would like to welcome Mavis Nye to our blog. Today, Mavis shares her story from the UK of how asbestos exposure led to her diagnosis of mesothelioma and her treatment journey fighting this disease. Mavis is currently a participant in a clinical trial exploring the effects of the drug Keytruda® which is providing a ray of hope for mesothelioma patients worldwide.
The Mesothelioma Cancer Alliance would like to welcome Lou Williams to our blog. Today, Lou shares her story of how the drug Keytruda® is helping her in her fight against mesothelioma and how she is campaigning to get this important treatment fast tracked on the Australian PBS (Pharmaceutical Benefits Scheme) in an effort to make it more readily available to mesothelioma patients in her country.
Each year, more than two million Americans report a poisoning to control centers around the United States, and more than 90 percent of these incidents happen inside the home. Poisonings are one of the leading causes of death among adults, while most non-fatal poisonings happen to children under the age of six.